[1] Palese P.Influenza: old and new threats[J]. Nature Medicine, 2004, 10(12): S82-S87. [2] Jonathan S, Nguyen V T, Chlos S.Avian influenza and the threat of the next human pandemic[J]. Journal of Hospital Infection, 2007, 65(2): 10-13. [3] de Clercq E. Antiviral drugs in current clinical use[J]. Journal of Clinical Virology, 2004, 30(2): 115-133. [4] Ilyushina N A, Elena A, Govorkova, et al. Detection of amantadine-resistant variants among avian influenza viruses isolated in North America and Asia[J]. Virology, 2005, 341(1): 102-106. [5] 龚震宇, 杨小平. 2009年甲型流感(H1N1)大流行病毒对达菲的耐药情况[J]. 疾病监测, 2009, 24(12): 983-984. [6] Valcic S, Muders A, Jacobsen N E, et al. Antioxidant chemistry of green tea catechins. Identification of products of the reaction of (-)-epigallocatechin gallate with peroxyl radicals[J]. Chemical Research in Toxicology, 1999, 12(4): 382-386. [7] Cho Y S, Schiller N L, Oh K H.Antibacterial Effects of Green Tea Polyphenols on Clinical Isolates of Methicillin-Resistant Staphylococcus aureus[J]. Current Microbiology, 2008, 57(6): 542-546. [8] Xu J, Wang J, Deng F, et al. Green tea extract and its major component epigallocatechin gallate inhibits hepatitis B virus in vitro[J]. Antiviral Research, 2008, 78(3): 242-249. [9] Nakayama M, Suzuki K, Toda M, et al. Inhibition of the infectivity of influenza virus by tea polyphenols[J]. Antiviral Research, 1993, 21(4): 289-299. [10] Imanishi N, Tuji Y, Katada Y, et al. Additional inhibitory effect of tea extract on the growth of influenza A and B viruses in MDCK cells[J]. Microbiology and Immunology, 2002, 46(7): 491-494. [11] Hayashi K, Sagesaka Y M, Suzuki T, et al. Inactivation of human type A and B influenza viruses by tea-seed saponins[J]. Bioscience Biotechnology and Biochemistry, 2000, 64(1): 184-186. [12] Mori S, Miyake S, Kobe T, et al. Enhanced anti-in?uenza A virus activity of(-)-epigallocatechin-3-O -gallate fatty acid monoester derivatives: Effect of alkyl chain length[J]. Bioorganic & Medicinal Chemistry Letters, 2008(18): 4249-4252. [13] Kruse P F, Patterson M K.Tissue culture: methods and applications[M]. New York and London: Academic Press, 1973. [14] Takeuchi H, Baba M, Shigeta S.An application of tetrazolium (MTT) colorimetric assay for the screening of anti-herpes simplex virus compounds[J]. J Virol Methods, 1991, 33(1-2): 61-71. [15] Chen J X, Xue H J, Ye W C, et al. Activity of Andrographolide and Its Derivatives against Influenza Virus in Vivo and in Vitro[J]. Biol. Pharm. Bull, 2009, 32(8): 1385-1391. [16] Song J M, Lee K H, Seong B L.Antiviral effect of catechins in green tea on influenza virus[J]. Antiviral Research, 2005, 68(2): 66-74. [17] Song J M, Park K D, Lee K H.Biological evaluation of anti-in?uenza viral activity of semi-synthetic catechin derivatives[J]. Antiviral Research, 2007(76): 178-185. [18] 刘艾林, 王海娣, 杨帆, 等. 抗流感神经氨酸酶抑制剂的研究进展[J]. 药学学报, 2009, 44(9): 935-942. [19] 张杰. 流感病毒神经氨酸酶抑制剂的设计、合成与初步活性研究[D]. 济南: 山东大学, 2008. [20] Ta T, Hirooka Y, Abe A, et al. Concise synthesis of dideoxy-epigallocatechin gallate (DO-EGCG) and evaluation of its anti-influenza virus activity[J]. Bioorganic & Medicinal Chemistry Letters, 2007, 17(11): 3095-3098. [21] Nagle D G, Ferreira D, Zho Y D, et al. Epigallocatechin-3-gallate (EGCG):Chemical and biomedical perspectives[J]. Phytochemistry, 2006(67): 1849-1855. |